Physician-Scientist (MD, MSc, PhDc) bridging Experimental Cardiology & Applied AI. I build systems that are safe, regulation-aware, and keep clinicians firmly in control.
Where clinical rigour meets software engineering.
Moving beyond "chatbots" to auditable workflows. I design systems with strict schema constraints, source-grounding, and mandatory human-in-the-loop (HITL) e-signatures.
Translating protocols into structured visit schedules. My implementation of LLM-assisted inventory tools reduced manual workload by ~90% while maintaining audit readiness.
PhD research in Heart Failure and oxidative stress. I bring the same methodological rigour from wet-lab high-throughput screening to AI validation (Z', S/B robustness).
From local LLMs (Ollama) to cloud deployments (Amazon Bedrock). I build reproducible MVPs using FastAPI and Docker that respect data privacy boundaries.
Recent roles and applied projects.
Orchestrated LLM workflows (Bedrock/Claude) for clinical reporting. Achieved ~80% reduction in hallucinations via prompt engineering and mandatory expert review layers.
Developed a FastAPI/Docker MVP for cardiovascular patient prioritization. Finalist at "Break The Gap 2025" for integrating biomarkers into transparent waitlist logic.
Experimental Cardiology. Investigating 5-oxoproline/OPLAH and oxidative stress. Focus on high-throughput assays, robust data analysis, and cardiorenal interactions.
Peer-reviewed research and high-impact abstracts.
Co-authored work integrating omics approaches to challenge conventional heart failure disease classification.
Investigation into intermediate filament degradation variants connecting dermatological and cardiac phenotypes.
Translational study linking 5-oxoproline accumulation to TGF-α and clinical outcomes in cardiorenal syndrome.
Conference abstract detailing the screening strategy for 5-oxoprolinase (OPLAH) enhancing molecules.